Pain Management in Breast Cancer Outpatients
Pain is reported by 25% to 89% of breast cancer patients during the disease process. This pain, which may be due to disease progression, surgery, or drug treatment, can range from mild to severe and can be of short or long duration. Little is known about how this pain is managed in the outpatient setting. Read more.
|
VTE Associated With Abemaciclib in Metastatic Breast Cancer
Despite the beneficial effect of abemaciclib, clinical trials have indicated that the drug has an incidence of venous thromboembolism (VTE) ranging from 4.8% to 6%; the latter percentage was 10-fold higher than that seen in the placebo group. Nonetheless, this may be an underestimation of risk given the restrictions and exclusion criteria of clinical trials. Read more.
|